Karen Cerosaletti

8.3k citations

65 papers · 4.2k indexed · 1 hit paper · h-index 30

Molecular Biology top 2%
Oncology top 2%
Immunology top 2%
Genetics top 2%
Cancer Research top 2%

Co-authors: Patrick Concannon Richard A. Gatti Jane H. Buckner Ami Desai‐Mehta S. Alice Long Mark O’Driscoll Markus Stümm Raymonda Varon
Topics: Immune Cell Function and Interaction (22 papers)Diabetes and associated disorders (20 papers)DNA Repair Mechanisms (19 papers)
Cited by: Cancer Research Immunology Oncology
Journals: Cell Nucleic Acids Research Journal of Biological Chemistry
Partner nations: United States United Kingdom Germany

In The Last Decade

Karen Cerosaletti

63 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome

1998 811 citations Raymonda Varon, Christine Vissinga et al. Cell profile →

Peers

Countries citing papers authored by Karen Cerosaletti

Since Specialization

Citations

This map shows the geographic impact of Karen Cerosaletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Cerosaletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Cerosaletti more than expected).

Fields of papers citing papers by Karen Cerosaletti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Cerosaletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Cerosaletti. The network helps show where Karen Cerosaletti may publish in the future.

Co-authorship network of co-authors of Karen Cerosaletti

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Cerosaletti. A scholar is included among the top collaborators of Karen Cerosaletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Cerosaletti. Karen Cerosaletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy 2024 ·Journal of Autoimmunity ·(unknown),Soo Jung Yang,Ethan McClain,Alex Hu,(unknown),(unknown),Janice Chen,(unknown),Akhilesh K. Singh,Eddie A. James,(unknown),Asma Siddique,David J. Rawlings,(unknown),Karen Cerosaletti,Jane H. Buckner	5
2	The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium 2024 ·Diabetologia ·Stephanie Hanna,Rachel H. Bonami,Brian Corrie,(unknown),Amanda L. Posgai,Eline T. Luning Prak,Felix Breden,Aaron W. Michels,Todd M. Brusko,Erin E. Baschal,Karen Cerosaletti,(unknown),Iria Gómez-Touriño,Lauren E. Higdon,Sally C. Kent,Peter S. Linsley,Maki Nakayama,(unknown),William Ruff,Luc Teyton	0
3	Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes 2023 ·JCI Insight ·Elisa Balmas,Janice Chen,Alex Hu,Hannah A. DeBerg,Mario G. Rosasco,Vivian H. Gersuk,Elisavet Serti,Cate Speake,Carla J. Greenbaum,Gerald T. Nepom,Peter S. Linsley,Karen Cerosaletti	9
4	A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab 2023 ·Diabetologia ·Chantal Mathieu,Alice Wiedeman,Karen Cerosaletti,S. Alice Long,(unknown),Laura G. Cooney,Joan Vermeiren,Silvia Caluwaerts,Karolien Van Huynegem,Lothar Steidler,(unknown),Pieter Rottiers,Gerald T. Nepom,Kevan C. Herold,(unknown)	38
5	HLA alleles and sustained peanut consumption promote IgG4 responses in subjects protected from peanut allergy 2022 ·Journal of Clinical Investigation ·Kanika Kanchan,(unknown),Henry T. Bahnson,Ingo Ruczinski,Gautam Shankar,David Larson,George Du Toit,Kathleen C. Barnes,Hugh A. Sampson,Mayte Suárez‐Fariñas,Gideon Lack,Gerald T. Nepom,Karen Cerosaletti,Rasika A. Mathias	17
6	Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes 2021 ·JCI Insight ·Peter S. Linsley,(unknown),Elisa Balmas,Hannah A. DeBerg,Kaitlin J. Flynn,Alex Hu,Mario G. Rosasco,Janice Chen,Colin O’Rourke,Elisavet Serti,Vivian H. Gersuk,(unknown),Howard R. Seay,Todd M. Brusko,William W. Kwok,Cate Speake,Carla J. Greenbaum,Gerald T. Nepom,Karen Cerosaletti	19
7	Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes 2017 ·The Journal of Immunology ·Karen Cerosaletti,(unknown),Junbao Yang,Hannah A. DeBerg,Matthew J. Dufort,Sara A. Murray,Elisabeth Israelsson,Cate Speake,Vivian H. Gersuk,James A. Eddy,Helena Reijonen,Carla J. Greenbaum,William W. Kwok,Erik Wambre,Martin Prlic,Raphaël Gottardo,Gerald T. Nepom,Peter S. Linsley	65
8	The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity 2017 ·Nature Immunology ·Jacquelyn A. Gorman,Christian Hundhausen,John S. Errett,Amy E.L. Stone,Eric J. Allenspach,Yan Ge,Tanvi Arkatkar,Courtnee Clough,Xuezhi Dai,Socheath Khim,Kathleen Pestal,Denny Liggitt,Karen Cerosaletti,Daniel B. Stetson,Richard G. James,Mohamed Oukka,Patrick Concannon,Michael Gale,Jane H. Buckner,David J. Rawlings	97
9	The BANK1 SLE-risk variants are associated with alterations in peripheral B cell signaling and development in humans 2016 ·Clinical Immunology ·(unknown),Tania Habib,Janice Chen,(unknown),Veronika Glukhova,(unknown),(unknown),Richard G. James,Jane H. Buckner,Karen Cerosaletti	26
10	Renegade homeostatic cytokine responses in T1D: Drivers of regulatory/effector T cell imbalance 2014 ·Clinical Immunology ·Shipra Gupta,Karen Cerosaletti,S. Alice Long	18
11	In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive T _regs Involves IL-6–Mediated Signaling 2013 ·Science Translational Medicine ·Anya Schneider,S. Alice Long,Karen Cerosaletti,Chester Ni,Peter L. Samuels,Mariko Kita,Jane H. Buckner	130
12	NBN Phosphorylation regulates the accumulation of MRN and ATM at sites of DNA double-strand breaks 2012 ·Oncogene ·Jie Wen,Karen Cerosaletti,(unknown),(unknown),Patrick Concannon	18
13	A novel mutation in a family with DNA ligase IV deficiency syndrome 2009 ·Pediatric Blood & Cancer ·Şule Ünal,Karen Cerosaletti,Duygu Uçkan,Mualla Çetin,Fatma Gümrük	24
14	Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1 2008 ·Human Molecular Genetics ·Tom Stiff,Karen Cerosaletti,Patrick Concannon,Mark O’Driscoll,Penny A. Jeggo	31
15	Nijmegen breakage syndrome: Clinical characteristics and mutation analysis in eight unrelated Russian families 2002 ·The Journal of Pediatrics ·Igor Resnick,Irina Kondratenko,(unknown),(unknown),(unknown),Oleg V. Evgrafov,Svetlana Tverskaya,Karen Cerosaletti,Richard A. Gatti,Patrick Concannon	54
16	Distinct Functional Domains of Nibrin Mediate Mre11 Binding, Focus Formation, and Nuclear Localization 2001 ·Molecular and Cellular Biology ·Ami Desai‐Mehta,Karen Cerosaletti,Patrick Concannon	159
17	ATM-dependent phosphorylation of nibrin in response to radiation exposure 2000 ·Nature Genetics ·Magtouf Gatei,David B. Young,Karen Cerosaletti,Ami Desai‐Mehta,Kevin J. Spring,Sergei Kozlov,Martin F. Lavin,Richard A. Gatti,Patrick Concannon,KumKum Khanna	393
18	Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndromebreakdown → 1998 ·Cell ·Raymonda Varon,Christine Vissinga,Matthias Platzer,Karen Cerosaletti,Krystyńa Chrzańowska,Kathrin Saar,Georg Beckmann,E Seemanová,Paul R. Cooper,Norma J. Nowak,Markus Stümm,Corry M.R. Weemaes,Richard A. Gatti,Richard K. Wilson,Martin Digweed,André Rosenthal,Karl Sperling,Patrick Concannon,André Reis	811
19	Alteration of the metastatic potential of line 1 lung carcinoma cells: Opposite effects of class I antigen induction by interferons versus DMSO or gene transfection 1990 ·Cellular Immunology ·Karen Cerosaletti,Timothy M. Blieden,(unknown),(unknown),John G. Frelinger,Edith M. Lord	13
20	Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cells. 1988 ·The Journal of Immunology ·David W. Bahler,Karen Cerosaletti,Edith M. Lord,John G. Frelinger	14

About Karen Cerosaletti

Karen Cerosaletti is a scholar working on Immunology, Cancer Research and Genetics, having authored 65 papers that have together received 4.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (22 papers), Diabetes and associated disorders (20 papers) and DNA Repair Mechanisms (19 papers). The work is most often cited by research in Cancer Research (929 citations), Immunology (1.1k citations) and Oncology (1.2k citations). Karen Cerosaletti has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Patrick Concannon, Richard A. Gatti, Jane H. Buckner, Ami Desai‐Mehta, S. Alice Long, Mark O’Driscoll, Markus Stümm, Raymonda Varon, Penny A. Jeggo and Christine Vissinga. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact